Artron BioResearch develops and manufactures, in a large-scale, a great array of high quality antibodies, antigens and critical components of RDT products for direct application in lateral flow tests (LFT) (fertility hormones, tumor markers, drugs of abuse, cardiac markers, infectious diseases, genetically modified organisms, etc), as well as other applications (chemiluminescence test, ELISA and research-based immunoassays).